Search results
25 sie 2022 · A number of over-the-counter (OTC) products are available to help treat symptoms of psoriasis. Learn about the most commonly used OTC products, and how they work to relieve symptoms.
9 cze 2023 · If other psoriasis treatments don’t work the way you want, your doctor may suggest a drug that fights the causes, rather than just eases the symptoms. These drugs are called biologics.
29 cze 2021 · Deucravacitinib (BMS-986165) is an oral Tyrosine kinase 2 (TYK2) selective inhibitor developed by Bristol-Myers Squibb for the treatment of moderate to severe chronic plaque psoriasis and psoriatic arthritis.
20 cze 2020 · Vials of biologics therapy. A valuable comparison of 11 biologic agents used to treat psoriasis and the commonly prescribed conventional systemic agent methotrexate is provided. The efficacy and safety data of 11 biologic agents for psoriasis treatment were outlined in a meta-analysis published in the British Journal of Dermatology.
1 wrz 2021 · The objective of this report is to summarize the evidence regarding the clinical effectiveness of newer biologic drugs compared to older biologic drugs in patients with moderate-to-severe plaque psoriasis.
17 maj 2024 · Biologics. These drugs, usually administered by injection, alter the immune system in a way that disrupts the disease cycle and improves symptoms and signs of disease within weeks. Several of these drugs are approved for the treatment of moderate to severe psoriasis in people who haven't responded to first line therapies.
7 lut 2024 · Methods. In this phase 2 dose-finding trial, we randomly assigned patients with moderate-to-severe plaque psoriasis to receive JNJ-77242113 at a dose of 25 mg once daily, 25 mg twice daily, 50...
